[{"NetIncomeLoss_1_Q1_USD":-29787000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":48229539.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q1_USD":-0.62,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":15256000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":53000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-30918000.0,"Depreciation_1_Q1_USD":110000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":30000.0,"AssetsCurrent_0_Q1_USD":481514000.0,"PrepaidExpenseAndOtherAssets_0_Q1_USD":4103000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":6378341.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":359000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":135000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":55500000.0,"CommonStockSharesIssued_0_Q1_shares":49024152.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":445616000.0,"Assets_0_Q1_USD":554588000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":12381000.0,"ShareBasedCompensation_1_Q1_USD":7055000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"EquityMethodInvestments_0_Q1_USD":3610000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":17375000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":2348000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":357000.0,"CommonStockValue_0_Q1_USD":5000.0,"OtherNonoperatingIncome_1_Q1_USD":3000.0,"InvestmentIncomeNet_1_Q1_USD":227000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":545000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":359000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":541000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-29775000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":879000.0,"OtherAssetsNoncurrent_0_Q1_USD":2547000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":95426000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1031000.0,"Liabilities_0_Q1_USD":19891000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":-33000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":12000.0,"OperatingLeaseLiability_0_Q1_USD":2275000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":916000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1697000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":12000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":83000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":7055000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-21104000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":63631000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1297000.0,"LiabilitiesCurrent_0_Q1_USD":18729000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-51663000.0,"AccountsPayableCurrent_0_Q1_USD":2229000.0,"NonoperatingIncomeExpense_1_Q1_USD":230000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":95991000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":359000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":658000.0,"AdditionalPaidInCapital_0_Q1_USD":683029000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1024000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-261000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":86373000.0,"CommonStockSharesOutstanding_0_Q1_shares":49024152.0,"LitigationSettlementExpense_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":73000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-697000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"OperatingIncomeLoss_1_Q1_USD":-29756000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":554588000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1920000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1244000.0,"OperatingExpenses_1_Q1_USD":29756000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":131000.0,"StockholdersEquity_0_Q1_USD":534697000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":45000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":445563000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-148390000.0,"MarketableSecurities_0_Q1_USD":381985000.0,"RestrictedCashNoncurrent_0_Q1_USD":565000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":889000.0,"Ticker":"SWTX","CIK":"1773427","name":"SPRINGWORKS THERAPEUTICS, INC.","OfficialName":"SpringWorks Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2504354261.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]